Iloperidone

In Brief: Study Finds No Link Between Antipsychotics and Gestational Diabetes

Given the number of younger women using atypical antipsychotic medications, we need more accurate data regarding the reproductive safety of these medications. To better understand the link between antipsychotic medication and medical conditions associated with [...]

By |2020-01-25T23:48:54-04:00May 18th, 2015|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Pregnancy Outcomes|Comments Off on In Brief: Study Finds No Link Between Antipsychotics and Gestational Diabetes

Meta-Analysis: Antipsychotics and Pregnancy Outcomes

Second-generation or “atypical” antipsychotics, such as olanzapine (Zyprexa), aripiprazole (Abilify), and risperidone (Risperdal), are used far more frequently than are the first-generation or “typical” antipsychotics, such as haloperidol (Haldol). This is largely because the newer [...]

By |2015-07-08T11:30:14-04:00May 6th, 2015|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Meta-Analysis: Antipsychotics and Pregnancy Outcomes

Antipsychotics and Pregnancy Part 2: Preliminary Data from the MGH Pregnancy Registry

This is the second part of a two part series on the use of antipsychotic medications during pregnancy.  Read Part 1 here, which reviews data from the Australian antipsychotic registry.

By |2016-03-28T13:23:55-04:00August 6th, 2014|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Antipsychotics and Pregnancy Part 2: Preliminary Data from the MGH Pregnancy Registry

Atypical Antipsychotic Medications: What Do We Know About Their Reproductive Safety?

Atypical antipsychotic medications are commonly used for the treatment of schizophrenia and bipolar disorder.  Despite the increasing use of these medications in women of child-bearing age, there is still relatively little data regarding the reproductive safety and long-term neurodevelopmental effects of these medications. A recent study assessed the development of 76 infants with fetal exposure to atypical antipsychotics.

By |2015-08-06T10:39:32-04:00May 15th, 2013|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Atypical Antipsychotic Medications: What Do We Know About Their Reproductive Safety?
Go to Top